March 31, 2010
Cellartis releases a new generation 2D Cardiomyocyte product, derived from pluripotent stem cells, for drug discovery and toxicity testing.
Cellartis has joined Cellectis stem cells since November 2011.
A perfect fit for the creation of a global leader in stem cells.
Download press release